Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10964744 | Vaccine | 2014 | 6 Pages |
Abstract
IMD, while encountered rarely in clinical practice, is considered an important disease to vaccinate against by FPs. Cost and perceived low socioeconomic status of patients are substantial barriers to FPs prescribing Men B and other non-funded vaccines, and inclusion of such vaccines on the National Immunisation Program is likely to improve equity of access.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Kathryn A. Taylor, Nigel Stocks, Helen S. Marshall,